Product Description
Milnacipran is a serotonin norepinephrine reuptake inhibitor (SNRI) used in the clinical treatment of fibromyalgia. It is not approved for the clinical treatment of major depressive disorder in the USA, but it is in other countries.High Quality and PurityMilnacipran API is offered in a highly pure form, boasting 99% potency, which is crucial for pharmaceutical manufacturing. Its consistent appearance, from white to off-white powder, ensures ease of use in various formulation processes, providing confidence in the final medicinal product.
Long Shelf StabilityWith a shelf life of up to five years, Milnacipran API offers excellent storage stability for manufacturers and suppliers. The stability of this API helps ensure reliable performance and consistent quality over time, reducing waste and ensuring compliance with regulatory standards.
Clinical Relevance and ApplicationAs a serotonin norepinephrine reuptake inhibitor (SNRI), Milnacipran is prominently utilized in the clinical treatment of fibromyalgia. Its precise action mechanism helps manage chronic pain and associated symptoms, making it a valuable compound for pharmaceutical developers and healthcare providers.
FAQ's of Milnacipran Api:
Q: How is Milnacipran API typically used in pharmaceutical formulations?
A: Milnacipran API is primarily used as an active pharmaceutical ingredient for developing medications targeting fibromyalgia. It can be formulated into tablets or capsules following standard industrial practices, and its high purity ensures effective therapeutic applications.
Q: What are the main benefits of using Milnacipran in clinical treatment?
A: The key benefit of Milnacipran is its ability to alleviate symptoms of fibromyalgia by inhibiting the reuptake of serotonin and norepinephrine in the brain, which helps manage pain and improve patients' quality of life.
Q: When should Milnacipran API be used during the drug manufacturing process?
A: Milnacipran API is used during the formulation stage of drug manufacturing. After the synthesis and purification of the powder, it is incorporated as the primary active component in medicinal preparations.
Q: Where is Milnacipran API sourced and supplied from?
A: Milnacipran API is exported, supplied, and traded from India, serving as a reliable source for pharmaceutical manufacturers worldwide seeking medicine-grade ingredients.
Q: What is the process for handling and storing Milnacipran API?
A: Milnacipran API should be handled in a controlled environment and stored in tightly sealed containers away from light, moisture, and excessive heat, ensuring its stability and shelf life of up to five years.
Q: Is Milnacipran API suitable for use in other therapies besides fibromyalgia?
A: While Milnacipran is primarily indicated for fibromyalgia, research on its use for other neurological disorders is ongoing. Its main approved usage remains in fibromyalgia management.